Mergers & Acquisitions - Mergers & Acquisitions

Filter

Current filters:

Mergers & Acquisitions

Popular Filters

1 to 25 of 916 results

Tau Therapeutics and Xdynia merge to form Cavion

29-08-2014

Privately-held US drugmakers Tau Therapeutics and Xdynia announced today that they have merged; the surviving…

CavionMergers & AcquisitionsNeurologicalOncologyPharmaceuticalTau TherapeuticsXdynia

Analysis of Roche’s InterMune acquisition

Analysis of Roche’s InterMune acquisition

28-08-2014

The acquisition of InterMune gives Swiss drug major Roche a substantial opportunity, owing to the Breakthrough…

BiotechnologyIdiopathic pulmonary fibrosisInterMuneMergers & AcquisitionspirfenidonePulmozymeRespiratory and PulmonaryRocheSwitzerlandXolair

Indian Pharma increasing capital and research spending

Indian Pharma increasing capital and research spending

28-08-2014

With over $50 billion worth of drugs set to go off patent over the next two years in the USA, Indian…

CiplaDr Reddy's LaboratoriesFinancialGenericsGlenmark PharmaceuticalsIndiaLupinMergers & AcquisitionsResearchSun Pharmaceuticals

Novo Nordisk buys production plant in New Hampshire

Novo Nordisk buys production plant in New Hampshire

27-08-2014

Danish diabetes care giant Novo Nordisk (NOV: N) said today that it has acquired a manufacturing facility…

Mergers & AcquisitionsNovo NordiskOlympus BiotechPharmaceuticalProductionUSA

Allergan moves to block Valeant and Pershing Square from voting shares acquired in violation of insider trading laws

27-08-2014

Hostile takeover target Allergan has asked the US District Court for the Central District of California…

AllerganLegalMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

China Biologic to up equity stake in Guizhou Taibang

China Biologic to up equity stake in Guizhou Taibang

26-08-2014

Plasma-based biopharma firm China Biologic Products says that its wholly-owned subsidiary Guiyang Dalin…

ChinaChina Biologic ProductsGuizhou Eakan PharmaceuticalGuizhou Taibang BiologicalMergers & AcquisitionsPharmaceutical

J&J affiliate Cilag GmbH International acquires Covagen

J&J affiliate Cilag GmbH International acquires Covagen

25-08-2014

Cilag GmbH International, an affiliate of US health care giant Johnson & Johnson’s Janssen companies,…

Anti-Arthritics/RheumaticsBiotechnologyCilag GmbH InternationalCovagenFynomAbInflammatory diseasesJanssenJohnson & JohnsonMergers & Acquisitions

Indian pharmaceutical sector to see strong growth, says Moody’s

Indian pharmaceutical sector to see strong growth, says Moody’s

25-08-2014

Moody's Investors Service says that India's pharmaceutical market will continue to grow in the double…

FinancialGenericsIndiaMarkets & MarketingMergers & Acquisitions

Roche makes another acquisition, paying $8.3 billion for InterMune

Roche makes another acquisition, paying $8.3 billion for InterMune

25-08-2014

Announcing its fourth acquisition this year, Swiss pharma major Roche said on Sunday that it has entered…

EsbrietInterMuneMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryRoche

Pershing Square and other shareholders call for special meeting regarding Allergan hostile bid

Pershing Square and other shareholders call for special meeting regarding Allergan hostile bid

23-08-2014

Pershing Square Capital Management, the largest shareholder of Allergan, which is the subject of a $53…

AllerganManagementMergers & AcquisitionsPharmaceuticalValeant Pharmaceuticals International

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

Pfizer could try to acquire Actavis as back-up to a further bid for AstraZeneca

22-08-2014

While speculation continues as to whether Pfizer will resume its attempts to buy AstraZeneca, Pfizer…

ActavisAstraZenecaBusiness FinanceIrelandMergers & AcquisitionsPfizerPharmaceuticalSwedenUKUnited StatesUSA

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

Mood lifts for Medtech in first half of 2014, while Pharma sector faces new struggles

20-08-2014

An M&A frenzy that accounted for nearly $90 billion of equity set the pace for the first half of 2014…

FinancialGlobalJonathan GardnerMergers & AcquisitionsPharmaceutical

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

EXPERT VIEW: Pfizer and AstraZeneca, a marriage not to be – yet?

19-08-2014

Mergers and acquisitions may excite the markets and shareholders on both sides but their record of success…

GlobalInterviewsMergers & AcquisitionsPharmaceutical

Pharming acquires Transgenic Rabbit Models assets and accesses five new product leads

Pharming acquires Transgenic Rabbit Models assets and accesses five new product leads

19-08-2014

Dutch biotech company Pharming Group says that, through the acquisition of certain assets of Transgenic…

BiotechnologyMergers & AcquisitionsNetherlandsPharmingPharming Group NVTreatment of Pompe’s disease

Roche said to be eyeing full control of Chugai

Roche said to be eyeing full control of Chugai

18-08-2014

Although the Swiss drug major has not issued a confirmation, media reports say Roche is close to acquiring…

Business FinanceChugai PharmaceuticalChugai Pharmaceutical Co.Chugai PharmaceuticalsHoffmann-La RocheInvestmentMergers & AcquisitionsPharmaceuticalRoche

$260.2 billion-worth of deals in the global PMB industry in first-half 2014

$260.2 billion-worth of deals in the global PMB industry in first-half 2014

12-08-2014

Global pharma, medical and biotechnology (PMB) M&A activity during the first half of 2014 hit the highest…

Business FinanceGlobalMergers & AcquisitionsPharmaceutical

Oncothyreon acquires Alpine Biosciences

Oncothyreon acquires Alpine Biosciences

12-08-2014

US biotech firm Oncothyreon says that it has acquired Alpine Biosciences, of Seattle, Washington, a privately…

Alpine BiosciencesBiotechnologyBusiness FinanceImmunotherapyMedicineMergers & AcquisitionsOncologyOncothyreonRare diseasesUSA

Allergan and Valeant receive second request for information from US Federal Trade Commission

Allergan and Valeant receive second request for information from US Federal Trade Commission

12-08-2014

US Botox maker Allergan has received a request for additional information from the US Federal Trade Commission…

AllerganBusiness FinanceMergers & AcquisitionsPharmaceuticalUSAValeant PharmaceuticalsValeant Pharmaceuticals International

uniQure acquires cardiology gene therapy firm InoCard

12-08-2014

Netherlands-based human gene therapy firm uniQure says it has acquired Germany’s InoCard GmbH, an innovative,…

BiotechnologyCardio-vascularGermanyInoCardMergers & AcquisitionsNetherlandsuniQure

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission

Sun Pharma’s takeover of Ranbaxy comes to attention of Competition Commission

11-08-2014

The deal between Indian generics company Sun Pharmaceutical Industries which acquired fellow Indian drug…

CCIGenericsIndiaMergers & AcquisitionsPharmaceuticalRanbaxy LaboratoriesSun Pharmaceutical Industries

Walgreens to buy remainder of Boots Alliance, but shuns inversion

06-08-2014

US pharmacy giant Walgreen has exercised its option to buy the remaining 55% of European pharmacy retailer…

Alliance BootsEuropeMarkets & MarketingMergers & AcquisitionsPharmaceuticalWalgreens

Kyowa Hakko Kirin subsidiary ProStrakan acquires Archimedes

Kyowa Hakko Kirin subsidiary ProStrakan acquires Archimedes

06-08-2014

Japanese drugmaker Kyowa Hakko Kirin subsidiary, the Scotland-based ProStrakan, has acquired Archimedes…

ArchimedesArchimedes PharmaFentanylJapanKyowa Hakko KirinMergers & AcquisitionsNovo A/SNovo NordiskPharmaceuticalProStrakan

Alvogen acquires Korean Dream Pharma for $187 million

Alvogen acquires Korean Dream Pharma for $187 million

06-08-2014

Privately-owned US generics firm Alvogen says it has acquired Dream Pharma in South Korea for $187 million…

AlvogenApac DistrictAsia-PacificBusiness FinanceDream PharmaGeneric pharmaceuticalGenericsMergers & AcquisitionsNorthern Region, UgandaPharmaceutical sciences

1 to 25 of 916 results

Back to top